Global biopharmaceutical company Gilead Sciences Inc. (Nasdaq: GILD) is closing its office in Seattle and laying off 72 ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that ...

The potential anchor tenant, a biotech firm based in the innovation district, is being recruited by other cities.

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with upcoming phase 3 study results.

With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $12.9 million in its third quarter. On a per-share basis, the Bay Harbor ...

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...